Compare CYRX & FSSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | FSSL |
|---|---|---|
| Founded | 1999 | 2010 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 774.7M | 885.2M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | FSSL |
|---|---|---|
| Price | $15.37 | $11.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $13.31 | N/A |
| AVG Volume (30 Days) | ★ 655.5K | 387.4K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.05% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | N/A | ★ 1.16 |
| Revenue | $176,177,000.00 | ★ $203,111,000.00 |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ N/A | $9.44 |
| Revenue Growth | N/A | ★ 5.41 |
| 52 Week Low | $6.69 | $10.75 |
| 52 Week High | $16.89 | $14.49 |
| Indicator | CYRX | FSSL |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 45.19 |
| Support Level | $14.54 | $10.78 |
| Resistance Level | $16.76 | $11.36 |
| Average True Range (ATR) | 0.81 | 0.22 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 13.66 | 39.62 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing primarily in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest primarily in a portfolio of secured and unsecured floating and fixed rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.